World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
113
Citations
48146
World Ranking
4946
National Ranking
2683

Overview

Steven M. Kornblau is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research primarily focuses on medicine, with significant contributions to the fields of hematology, molecular biology, public health, environmental and occupational health, genetics, and oncology.

The scientist's work covers a range of topics, including:

  • Acute Myeloid Leukemia Research
  • Acute Lymphoblastic Leukemia Research
  • Chronic Myeloid Leukemia Treatments
  • Chronic Lymphocytic Leukemia Research
  • Histone Deacetylase Inhibitors Research
  • Multiple Myeloma Research and Treatments
  • CAR-T Cell Therapy Research

Steven M. Kornblau has published extensively in journals such as:

  • Blood
  • Clinical Lymphoma Myeloma & Leukemia
  • Journal of Clinical Oncology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Blood Cancer Journal

Recent published papers include:

  • "Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML," 2020, Blood
  • "Venetoclax Combined With FLAG-IDA Induction and Consolidation in Newly Diagnosed and Relapsed or Refractory Acute Myeloid Leukemia," 2021, Journal of Clinical Oncology
  • "10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial," 2020, The Lancet Haematology
  • "Enhancer Hijacking Drives Oncogenic BCL11B Expression in Lineage-Ambiguous Stem Cell Leukemia," 2021, Cancer Discovery
  • "Venetoclax plus intensive chemotherapy with cladribine, idarubicin, and cytarabine in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a cohort from a single-centre, single-arm, phase 2 trial," 2021, The Lancet Haematology

The scientist frequently collaborates with peers, among the most common co-authors being:

  • Tapan M. Kadia
  • Elias Jabbour
  • Guillermo Garcia-Manero
  • Farhad Ravandi
  • Courtney D. DiNardo

Best Publications

  • Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia

    Timothy J. Ley;Christopher Miller;Li Ding;Benjamin J. Raphael

  • Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia

    K. G. Roberts;Y. Li;D. Payne-Turner;R. C. Harvey

  • Engraftment of Allogeneic Hematopoietic Progenitor Cells With Purine Analog-Containing Chemotherapy: Harnessing Graft-Versus-Leukemia Without Myeloablative Therapy

    Sergio Giralt;Elihu Estey;Maher Albitar;Koen Van Besien

  • Expression and Prognostic Significance of IAP-Family Genes in Human Cancers and Myeloid Leukemias

    Ingo Tamm;Steven M. Kornblau;Harry Segall;Stanislaw Krajewski

  • Melphalan and purine analog–containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

    Sergio Giralt;Peter F. Thall;Issa Khouri;Xuemei Wang

  • MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia

    Ramiro Garzon;Stefano Volinia;Stefano Volinia;Chang-Gong Liu;Cecilia Fernandez-Cymering

  • Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells

    Raoul Tibes;Yi Hua Qiu;Yiling Lu;Bryan Hennessy

  • Treatment of Philadelphia chromosome–positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate

    Deborah A. Thomas;Stefan Faderl;Jorge Cortes;Susan O'Brien

  • Recommended Guidelines for the Treatment of Cancer Treatment-Induced Diarrhea

    Al B. Benson;Jaffer A. Ajani;Robert B. Catalano;Constance Engelking

  • MicroRNA 29b functions in acute myeloid leukemia.

    Ramiro Garzon;Catherine E. A. Heaphy;Violaine Havelange;Muller Fabbri

  • Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML.

    C. D. DiNardo;I. S. Tiong;I. S. Tiong;A. Quaglieri;S. MacRaild

  • PAX5 -driven subtypes of B-progenitor acute lymphoblastic leukemia

    Zhaohui Gu;Michelle L. Churchman;Kathryn G. Roberts;Ian Moore

  • Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study.

    Naval Daver;Guillermo Garcia-Manero;Sreyashi Basu;Prajwal C Boddu

  • Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemia

    Michele Milella;Steven M. Kornblau;Zeev Estrov;Bing Z. Carter

  • Treatment of Adult T-Cell Leukemia–Lymphoma with a Combination of Interferon Alfa and Zidovudine

    Parkash S. Gill;William Harrington;Mark H. Kaplan;Raul C. Ribeiro

  • High Frequency and Poor Outcome of Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia in Adults.

    Kathryn G. Roberts;Zhaohui Gu;Debbie Payne-Turner;Kelly McCastlain

  • Use of granulocyte colony-stimulating factor before, during, and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: comparison with fludarabine plus cytarabine without granulocyte colony-stimulating factor.

    E Estey;P Thall;M Andreeff;M Beran

  • Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults

    Nitin Jain;Kathryn G. Roberts;Elias Jabbour;Keyur Patel

  • BCR-ABL1 compound mutations combining key kinase domain positions confer clinical resistance to ponatinib in Ph chromosome-positive leukemia.

    Matthew S. Zabriskie;Christopher A. Eide;Christopher A. Eide;Srinivas K. Tantravahi;Nadeem A. Vellore

  • Inhibition of the Mitochondrial Protease ClpP as a Therapeutic Strategy for Human Acute Myeloid Leukemia

    Alicia Cole;Zezhou Wang;Etienne Coyaud;Veronique Voisin

Frequent Co-Authors

Hagop M. Kantarjian
Hagop M. Kantarjian The University of Texas MD Anderson Cancer Center
Michael Andreeff
Michael Andreeff The University of Texas MD Anderson Cancer Center
Marina Konopleva
Marina Konopleva The University of Texas MD Anderson Cancer Center
Jorge E. Cortes
Jorge E. Cortes Augusta University
Guillermo Garcia-Manero
Guillermo Garcia-Manero The University of Texas MD Anderson Cancer Center
Farhad Ravandi
Farhad Ravandi The University of Texas MD Anderson Cancer Center
Gautam Borthakur
Gautam Borthakur The University of Texas MD Anderson Cancer Center
Elias Jabbour
Elias Jabbour The University of Texas MD Anderson Cancer Center
Naval Daver
Naval Daver The University of Texas MD Anderson Cancer Center
Sherry Pierce
Sherry Pierce The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering the medical field in the USA, there are a range of online degrees and career pathways worth exploring. Online learning makes many high-demand healthcare degrees more accessible, letting you balance career advancement with your current responsibilities.

For those interested in health administration rather than direct patient care, cahme-accredited Master of Health Administration (MHA) programs provide flexible options to enter leadership and management roles. These programs can prepare graduates for in-demand positions in hospitals and healthcare organizations.

If you are a registered nurse aiming to advance, online rn to bsn no clinicals programs offer a fast track to earning your Bachelor of Science in Nursing, often without the need for on-site clinical requirements.

Nurses seeking to reach the highest clinical levels can consider online dnp programs. These Doctor of Nursing Practice (DNP) degrees are available in accelerated, flexible formats. If you're looking for less intensive coursework, explore the dnp programs online that are designed for ease and speed.

Each of these pathways opens unique doors, giving you more control over your career while gaining the skills vital for today’s healthcare landscape.

Best Scientists Citing Steven M. Kornblau

Trending Scientists

Recently Published Articles